Terms: = Gastric cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Prognosis
112 results:
1. Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression.
Deng C; Huo M; Chu H; Zhuang X; Deng G; Li W; Wei H; Zeng L; He Y; Liu H; Li J; Zhang C; Chen H
Mol Cancer; 2024 Mar; 23(1):49. PubMed ID: 38459596
[TBL] [Abstract] [Full Text] [Related]
2. Downregulation of PDIA3 inhibits gastric cancer cell growth through cell cycle regulation.
Yang M; Li Q; Yang H; Li Y; Lu L; Wu X; Liu Y; Li W; Shen J; Xiao Z; Zhao Y; Du F; Chen Y; Deng S; Cho CH; Li X; Li M
Biomed Pharmacother; 2024 Apr; 173():116336. PubMed ID: 38412717
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA-CCAT5-mediated crosstalk between Wnt/β-Catenin and stat3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity.
Liu C; Shen A; Song J; Cheng L; Zhang M; Wang Y; Liu X
Cancer Commun (Lond); 2024 Jan; 44(1):76-100. PubMed ID: 38010289
[TBL] [Abstract] [Full Text] [Related]
4. AGAP2-AS1 promotes the assembly of m6A methyltransferases and activation of the IL6/stat3 pathway by binding with WTAP in the carcinogenesis of gastric cancer.
Nie K; Zheng Z; Li J; Chang Y; Deng Z; Huang W; Li X
FASEB J; 2023 Dec; 37(12):e23302. PubMed ID: 37983949
[TBL] [Abstract] [Full Text] [Related]
5. Mechanisms of cellular crosstalk in the gastric tumor microenvironment are mediated by YAP1 and stat3.
Thilakasiri P; O'Keefe RN; To SQ; Chisanga D; Eissmann MF; Carli AL; Duscio B; Baloyan D; Dmello RS; Williams D; Mariadason J; Poh AR; Pal B; Kile BT; Vissers JH; Harvey KF; Buchert M; Shi W; Ernst M; Chand AL
Life Sci Alliance; 2024 Feb; 7(2):. PubMed ID: 37957015
[TBL] [Abstract] [Full Text] [Related]
6. Exosomes-mediated transfer of LINC00691 regulates the formation of CAFs and promotes the progression of gastric cancer.
Xia B; Gu X; Xu T; Yan M; Huang L; Jiang C; Li M; Zhai G; Zhang G; Wu J; Zhou Y; Sun C; Liang W
BMC Cancer; 2023 Oct; 23(1):928. PubMed ID: 37784036
[TBL] [Abstract] [Full Text] [Related]
7. RHOJ Induces Epithelial-to-Mesenchymal Transition by IL-6/stat3 to Promote Invasion and Metastasis in gastric cancer.
Ma Z; Sun Q; Zhang C; Zheng Q; Liu Y; Xu H; He Y; Yao C; Chen J; Xia H
Int J Biol Sci; 2023; 19(14):4411-4426. PubMed ID: 37781036
[No Abstract] [Full Text] [Related]
8. SEC23A confers ER stress resistance in gastric cancer by forming the ER stress-SEC23A-autophagy negative feedback loop.
Cheng Q; Liu K; Xiao J; Shen K; Wang Y; Zhou X; Wang J; Xu Z; Yang L
J Exp Clin Cancer Res; 2023 Sep; 42(1):232. PubMed ID: 37670384
[TBL] [Abstract] [Full Text] [Related]
9. Reduced DEFA5 Expression and stat3 Activation Underlie the Submucosal Invasion of Early gastric cancers.
Nagao S; Takahashi Y; Denda T; Tanaka Y; Miura Y; Mizutani H; Ohki D; Sakaguchi Y; Yakabi S; Tsuji Y; Niimi K; Kakushima N; Yamamichi N; Ota Y; Koike K; Fujishiro M
Digestion; 2023; 104(6):480-493. PubMed ID: 37598668
[TBL] [Abstract] [Full Text] [Related]
10. Predicting response to immunotherapy in gastric cancer via assessing perineural invasion-mediated inflammation in tumor microenvironment.
Li X; Wang Y; Zhai Z; Mao Q; Chen D; Xiao L; Xu S; Wu Q; Chen K; Hou Q; He Q; Shen Y; Yang M; Peng Z; He S; Zhou X; Tan H; Luo S; Fang C; Li G; Chen T
J Exp Clin Cancer Res; 2023 Aug; 42(1):206. PubMed ID: 37563649
[TBL] [Abstract] [Full Text] [Related]
11. LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m
Fang Y; Wu X; Gu Y; Shi R; Yu T; Pan Y; Zhang J; Jing X; Ma P; Shu Y
Clin Transl Med; 2023 Mar; 13(3):e1205. PubMed ID: 36864711
[TBL] [Abstract] [Full Text] [Related]
12. Dual inhibition of MYC and SLC39A10 by a novel natural product stat3 inhibitor derived from Chaetomium globosum suppresses tumor growth and metastasis in gastric cancer.
Guan X; Yang J; Wang W; Zhao B; Hu S; Yu D; Yuan L; Shi Y; Xu J; Dong J; Wang J; Cheng XD; Qin JJ
Pharmacol Res; 2023 Mar; 189():106703. PubMed ID: 36804016
[TBL] [Abstract] [Full Text] [Related]
13. Rab31 promotes metastasis and cisplatin resistance in stomach adenocarcinoma through Twist1-mediated EMT.
Chen K; Xu J; Tong YL; Yan JF; Pan Y; Wang WJ; Zheng L; Zheng XX; Hu C; Hu X; Shen X; Chen W
Cell Death Dis; 2023 Feb; 14(2):115. PubMed ID: 36781842
[TBL] [Abstract] [Full Text] [Related]
14. MARCO is a potential prognostic and immunotherapy biomarker.
Dong Q; Zhang S; Zhang H; Sun J; Lu J; Wang G; Wang X
Int Immunopharmacol; 2023 Mar; 116():109783. PubMed ID: 36773567
[TBL] [Abstract] [Full Text] [Related]
15. HOXB7 induces stat3-mediated transformation and lung metastasis in immortalized mammary gland NMuMG cells.
Azuma K; Sakamoto M; Katayama S; Matsui A; Nakamichi K; Goshima N; Watanabe S; Nakayama J; Semba K
Genes Cells; 2023 Apr; 28(4):277-287. PubMed ID: 36659836
[TBL] [Abstract] [Full Text] [Related]
16. BGN/FAP/stat3 positive feedback loop mediated mutual interaction between tumor cells and mesothelial cells contributes to peritoneal metastasis of gastric cancer.
Wu H; Xiang Z; Huang G; He Q; Song J; Dou R; Yang C; Wang S; Xiong B
Int J Biol Sci; 2023; 19(2):465-483. PubMed ID: 36632455
[TBL] [Abstract] [Full Text] [Related]
17. Downregulation of CYRI-B promotes migration, invasion and EMT by activating the Rac1-stat3 pathway in gastric cancer.
Liu G; Xia Y; Wang H; Jin X; Chen S; Chen W; Zhang C; He Y
Exp Cell Res; 2023 Feb; 423(1):113453. PubMed ID: 36584745
[TBL] [Abstract] [Full Text] [Related]
18. A cohort study using IL-6/stat3 activity and PD-1/PD-L1 expression to predict five-year survival for patients after gastric cancer resection.
Li XN; Peng YH; Yue W; Tao L; Zhang WJ
PLoS One; 2022; 17(12):e0277908. PubMed ID: 36454780
[TBL] [Abstract] [Full Text] [Related]
19. Exploring the mechanism of andrographolide in the treatment of gastric cancer through network pharmacology and molecular docking.
Yadav RP; Sadhukhan S; Saha ML; Ghosh S; Das M
Sci Rep; 2022 Nov; 12(1):18413. PubMed ID: 36319798
[TBL] [Abstract] [Full Text] [Related]
20. [Nur77 promotes invasion and migration of gastric cancer cells through the NF-κB/IL-6 pathway].
Li W; Shi Y; Guo Y; Tian S
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Sep; 42(9):1410-1417. PubMed ID: 36210716
[TBL] [Abstract] [Full Text] [Related]
[Next]
